𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The impact of intraoperative ultrasonography on the surgical treatment of patients with colorectal liver metastases

✍ Scribed by C. Sietses; M. R. Meijerink; S. Meijer; M. P. van den Tol

Publisher
Springer
Year
2010
Tongue
English
Weight
173 KB
Volume
24
Category
Article
ISSN
0930-2794

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of portal vein embolization on lo
Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases
✍ D. A. Wicherts; R. J. de Haas; P. Andreani; D. Sotirov; C. Salloum; D. Castaing; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 154 KB πŸ‘ 2 views

## Abstract ## Background Portal vein embolization (PVE) increases the resectability of initially unresectable colorectal liver metastases (CLM). This study evaluated long-term survival in patients with CLM who underwent hepatectomy following PVE. ## Methods In a retrospective analysis patients

Assessing the optimal duration of chemot
Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases
✍ Rebekah R. White; Lawrence H. Schwartz; Jose A. Munoz; Greer Raggio; William R. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 124 KB

## Abstract ## Background and Objectives Few studies have addressed the optimal duration of chemotherapy, particularly prior to liver resection for colorectal liver metastases (CLM). The purpose of this retrospective analysis was to evaluate time to maximal response in patients receiving systemic 

Cost-effectiveness of systemic and regio
Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases
✍ Isabelle Durand-Zaleski; Sally Earlam; Carol Fordy; Michael Davies; Timothy G. A πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 3 views

## Background: Management of unresectable colorectal liver metastases (clm) can be by regional (hepatic arterial infusion [hai]) or systemic chemotherapy, or by symptom control alone. in this study the costs of each type of management were related to clinical outcome in 134 patients with clm. ## M